Evidence of benefit from centralised treatment of ovarian cancer: A nationwide population-based survival analysis in Finland

International Journal of Cancer

Volumn 102, Issue 5, 2002, Pages 541-544

  Kumpulainen, Salla ^a,b   Grénman, Seija ^b   Kyyrönen, Pentti ^a   Pukkala, Eero ^a   Sankila, Risto ^a,c  

^a Institute for Statistical and Epidemiological Cancer Research   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NONE   (Finland)

Author keywords

Cancer epidemiology; Centralized treatment; Operative treatment; Optimal care; Ovarian cancer; Survival rates

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; FEMALE; FINLAND; HOSPITAL; HUMAN; INFANT; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; SURGICAL PATIENT; UNIVERSITY HOSPITAL;

AGED; CENTRALIZED HOSPITAL SERVICES; FEMALE; FINLAND; HOSPITAL MORTALITY; HOSPITALS; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; ONCOLOGY SERVICE, HOSPITAL; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; RISK; SURGERY DEPARTMENT, HOSPITAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037058698     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10754     Document Type: Article

References (25)

1. Hoskins WJ. Epithelial ovarian carcinoma: Principles of primary surgery. Gynecol Oncol 1994;55:91-6.
2. Ozols RT, Rubin SC, Thomas G, Rubboy S. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. 2nd Ed. Philadelphia: Lippincott-Raven, 1997. 941.
3. Trimble EL, Kosari CA, Cornelison TL, Christian MC. Improved survival for women with ovarian cancer. Gynecol Oncol 1999;72:458.
4. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975;42:101-4.
5. Omura GA, Bundy BN, Berek JS, Curry S, Delgado G, Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 1989;7:457-65.
6. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Survival impact of surgical cytoreduction in Stage IV epithelial ovarian cancer. Gynecol Oncol 1999;72:278-87.
7. Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang HJ. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 1992;47:203-9.
8. Nguyen HN, Averette HE, Hoskins W, Penalver M, Sevin B, Steren A. National survey of ovarian carcinoma. Part V: The impact of physician's specialty on patients' survival. Cancer 1993;72:3663-70.
9. Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynecologists and survival outcome in ovarian cancer: A Scottish national study of 1866 patients. Br J Obstet Gynaecol 1999;106:1130-6.
10. Mayer AR, Chambers SK, Graves E, Holm C, Tseng PC, Nelson BE, Schwartz PE. Ovarian cancer staging: Does it require a gynecologic oncologist? Gynecol Oncol 1992;47:223-7.
11. McGowan L. Patterns of care in carcinoma of the ovary. Cancer 1993;71(Suppl):628-33.
12. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol 1998;69:103-8.
13. Bertelsen K. Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA study. Gynecol Oncol 1990;38:203-9.
14. Wolfe CDA, Tilling K, Raju KS. Management and survival of ovarian cancer patients in South East England. Eur J Cancer 1997;33:1835-40.
15. Gillis CR, Hole DJ, Still RM, Davis J, Kaye SB. Medical audit, cancer registration, and survival in ovarian cancer. Lancet 1991;337:611-2.
16. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: Referral to a multidisciplinary team matters. Br J Cancer 1994;70:363-70.
17. Woodman C, Baghdady A, Collins S, Clyma JA. What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer? Br J Obstet Gynaecol 1997;104:135-9.
18. Accounts Commission for Scotland. Fighting the Silent Killer: Optimizing Ovarian Cancer Management in Scotland. Edinburgh: The Commission, 1998.
19. National Cancer Guidance Steering Group. Improving Outcomes in Gynecological Cancers: The Research Evidence. London: NHS Executive, Department of Health, 1999.
20. National Cancer Guidance Steering Group. Improving Outcomes in Gynecological Cancers: The Manual. London: NHS Executive, Department of Health, 1999.
21. Guidelines for Referral to a Gynaecologic Oncologist: Rationale and Benefits. A Special Issue by the Society of Gynecological Oncologists. Gynecol Oncol 2000;78(3):S7-8.
22. FIGO Annual Report 2001. J Epidemiol Biostat 2001;6:1-184.
23. Gatta G, Lasota MB, Verdecchia A, EUROCARE Working Group. Survival of European women with gynecological tumors during the period 1978-1989. Eur J Cancer 1998;34:2218-25.
24. Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Söderman B. Survival of cancer patients in Finland 1955-1994. Acta Oncol 1999;38(Suppl):55-7.
25. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.